CUFinder

Paul Loadman

Paul Loadman

University of Bradford

H-index: 46

Europe-United Kingdom

Contact Paul Loadman

About Paul Loadman

Paul Loadman, With an exceptional h-index of 46 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Bradford, specializes in the field of Pharmacokinetics, Drug metabolism, Drug delivery, Cancer Pharmacology, Prodrug design.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in …

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp …

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

Colorectal polyp outcomes after participation in the se AFO od polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use

Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues

Paul Loadman Information

University

Position

Professor of Pharmacokinetics and Drug Metabolism

Citations(all)

6068

Citations(since 2020)

2300

Cited By

4899

hIndex(all)

46

hIndex(since 2020)

25

i10Index(all)

100

i10Index(since 2020)

57

Email

University Profile Page

Google Scholar

Paul Loadman Skills & Research Interests

Pharmacokinetics

Drug metabolism

Drug delivery

Cancer Pharmacology

Prodrug design

Top articles of Paul Loadman

Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in …

Cancer Research

2024/4/5

Natalie Cook
Natalie Cook

H-Index: 18

Paul Loadman
Paul Loadman

H-Index: 25

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp …

International Journal of Cancer

2024/3/1

Ge Sun
Ge Sun

H-Index: 2

Amy Downing
Amy Downing

H-Index: 20

Elizabeth A Williams
Elizabeth A Williams

H-Index: 11

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

BMJ open

2023/11/1

Mingyang Song
Mingyang Song

H-Index: 44

Omer Yilmaz
Omer Yilmaz

H-Index: 1

David A Drew
David A Drew

H-Index: 15

Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

Cancer Prevention Research

2023/11/1

Amy Downing
Amy Downing

H-Index: 20

Elizabeth A Williams
Elizabeth A Williams

H-Index: 11

Colorectal polyp outcomes after participation in the se AFO od polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use

Alimentary Pharmacology & Therapeutics

2023/9

Amy Downing
Amy Downing

H-Index: 20

Elizabeth A Williams
Elizabeth A Williams

H-Index: 11

Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial

Prostaglandins, Leukotrienes and Essential Fatty Acids

2023/5/1

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

BMJ Open

2023

Mingyang Song
Mingyang Song

H-Index: 44

Omer Yilmaz
Omer Yilmaz

H-Index: 1

David A Drew
David A Drew

H-Index: 15

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues

Iscience

2023/11/17

Simon Ward
Simon Ward

H-Index: 3

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Cancer Medicine

2022/10

Sonja Khan
Sonja Khan

H-Index: 66

Sudipto Das
Sudipto Das

H-Index: 1

Claudio Isella
Claudio Isella

H-Index: 20

Paul Loadman
Paul Loadman

H-Index: 25

Kathleen Bennett
Kathleen Bennett

H-Index: 44

Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells

Biochemical Pharmacology

2022/7/1

Cellular uptake and metabolism of MT1-MMP-activated taxane prodrugs

Cancer Research

2022/6/15

Hannah Spencer
Hannah Spencer

H-Index: 5

Paul Loadman
Paul Loadman

H-Index: 25

Intermittent PI3Ko inhibition sustains anti-tumor immunity and curbs irAEs

2022/5/26

Y Li
Y Li

H-Index: 15

J Thomas
J Thomas

H-Index: 10

Rp Singh
Rp Singh

H-Index: 3

Paul Loadman
Paul Loadman

H-Index: 25

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Nature

2022/5/26

Ciro Ramírez-Suástegui
Ciro Ramírez-Suástegui

H-Index: 6

Alice Wang
Alice Wang

H-Index: 10

Fiona Kelly
Fiona Kelly

H-Index: 7

Richard Shaw
Richard Shaw

H-Index: 5

William Wilson
William Wilson

H-Index: 8

Klaus Okkenhaug
Klaus Okkenhaug

H-Index: 41

Gareth J Thomas
Gareth J Thomas

H-Index: 41

Bart Vanhaesebroeck
Bart Vanhaesebroeck

H-Index: 51

A Single Short ‘Tone Burst’Results in Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic Microbubbles

Pharmaceutics

2022/3/11

Nicola Ingram
Nicola Ingram

H-Index: 16

The role of MT1-MMP in the progression and metastasis of osteosarcoma

2022

Paul Loadman
Paul Loadman

H-Index: 25

Cytochrome P450 binding and bioactivation of tumor-targeted duocarmycin agents

Drug Metabolism and Disposition

2022/1/1

Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid

Cancer Chemotherapy and Pharmacology

2021/6

Nicola Ingram
Nicola Ingram

H-Index: 16

Anna Nicolaou
Anna Nicolaou

H-Index: 6

An assay for quantitative analysis of polysialic acid expression in cancer cells

Carbohydrate Polymers

2021/5/1

Steven D Shnyder
Steven D Shnyder

H-Index: 23

Laurence H Patterson
Laurence H Patterson

H-Index: 20

Immunomodulatory effects of PI3Kδ inhibition in solid tumors–evaluation in a randomized phase II trial

2021/3/19

Christian Ottensmeier
Christian Ottensmeier

H-Index: 44

Alice Wang
Alice Wang

H-Index: 10

Fiona Kelly
Fiona Kelly

H-Index: 7

Richard Shaw
Richard Shaw

H-Index: 5

Paul Loadman
Paul Loadman

H-Index: 25

William Wilson
William Wilson

H-Index: 8

Klaus Okkenhaug
Klaus Okkenhaug

H-Index: 41

Gareth Thomas
Gareth Thomas

H-Index: 11

Terry Jones
Terry Jones

H-Index: 130

Bart Vanhaesebroeck
Bart Vanhaesebroeck

H-Index: 51

Methods of treating cancer using compounds containing a vascular disrupting agent

2021/2/9

See List of Professors in Paul Loadman University(University of Bradford)